Pharmachal has signed an agreement with NASDAQ-listed company NutraPharma Corporation to distribute pain-relief product Nyloxin in Australia and New Zealand.   

​

Formulated using Asian cobra venom, Nyloxin provides all-natural anti-inflammatory analgesic pain relief that is:

• Non-toxic

• Non-narcotic

• Non-addictive

• Non-steroidal

• Contains no aspirin or acetaminophen.

Safe to use without a prescription, it treats conditions that cause chronic pain.

​

The range currently has FDA-registration in the USA.  Pharmachal is currently registering the products with TGA in Australia.

 

Find out more about Nyloxin.

​

 https://nyloxin.com/